{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:54Z","timestamp":1791389094979,"version":"4.3.3"},"update-to":[{"DOI":"10.1002\/14651858.cd001841.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000}}],"reference-count":246,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001841.pub3","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T07:53:08Z","timestamp":1524037988000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["First-line drugs for hypertension"],"prefix":"10.1002","volume":"2018","author":[{"given":"James M","family":"Wright","sequence":"first","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya M","family":"Musini","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupam","family":"Gill","sequence":"additional","affiliation":[{"name":"Manipal University; Department of Pharmacology; Manipal India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD001841.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.HYP.6.5.774","article-title":"The Australian therapeutic trial in mild hypertension","volume":"6","author":"Abernethy","year":"1984","journal-title":"Hypertension"},{"issue":"22","key":"10.1002\/14651858.CD001841.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1001\/jama.1986.03380220100031","article-title":"The need to treat mild hypertension. Misinterpretation of results from the Australian trial","volume":"256","author":"Abernethy","year":"1986","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001841.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/00005344-198507002-00003","article-title":"Cardiovascular morbidity and mortality in mild hypertension: the Australian trial","volume":"7","author":"Doyle","year":"1985","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001841.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000184567","article-title":"The Australian therapeutic trial in mild hypertension","volume":"47","author":"Doyle","year":"1987","journal-title":"Nephron"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"449s","DOI":"10.1042\/cs057449s","article-title":"Initial results of the Australian therapeutic trial in mild hypertension. Report by the Management Committee","volume":"57","author":"Management Committee","year":"1979","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0006|cit6","first-page":"1261","article-title":"The Australian therapeutic trial in mild hypertension. Report by the Management Committee","volume":"1","author":"Management Committee","year":"1980","journal-title":"Lancet"},{"issue":"8265","key":"10.1002\/14651858.CD001841.pub3-BIB0007|cit7","first-page":"185","article-title":"Untreated mild hypertension. A report by the Management Committee of the Australian Therapeutic Trial in Mild Hypertension","volume":"1","author":"Management Committee","year":"1982","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5694\/j.1326-5377.1981.tb101027.x","article-title":"Treatment of mild hypertension in the elderly. A study initiated and administered by the National Heart Foundation of Australia","volume":"2","author":"National Heart Foundation of Australia","year":"1981","journal-title":"Medical Journal of Australia"},{"issue":"8191","key":"10.1002\/14651858.CD001841.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(80)90471-7","article-title":"Australian therapeutic trial in mild hypertension","volume":"2","author":"Parry","year":"1980","journal-title":"Lancet"},{"issue":"13","key":"10.1002\/14651858.CD001841.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.5694\/j.1326-5377.1984.tb132588.x","article-title":"Australian therapeutic trial in mild hypertension","volume":"140","author":"Reader","year":"1984","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0011|cit11","first-page":"434","article-title":"Control of moderately raised blood pressure. Report of a co-operative randomized controlled trial","volume":"III","author":"Barraclough","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(70)91577-1","article-title":"Hypotensive therapy in stroke survivors","volume":"I","author":"Carter","year":"1970","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/01.STR.24.4.543","article-title":"Trial of secondary prevention with atenolol after transient ischemic attack or non-disabling ischemic stroke","volume":"24","author":"Dutch TIA Trial Study Group","year":"1993","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0014|cit14","first-page":"263s","article-title":"Antihypertensive therapy in patients above age 60 years. Fourth interim report of the European Working Party on High Blood Pressure in the Elderly","volume":"55","author":"Amery","year":"1978","journal-title":"Clinical Science and Molecular Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001841.pub3-BIB0015|cit15","first-page":"113","article-title":"Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High Blood Pressure in the Elderly","volume":"33","author":"Amery","year":"1978","journal-title":"Acta Cardiologica"},{"issue":"6","key":"10.1002\/14651858.CD001841.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000212219","article-title":"Antihypertensive therapy in elderly patients. Pilot trial of the European Working Party on High Blood Pressure in the Elderly","volume":"23","author":"Amery","year":"1977","journal-title":"Gerontology"},{"issue":"732","key":"10.1002\/14651858.CD001841.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/pgmj.62.732.919","article-title":"Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the European Working Party on High Blood Pressure in the Elderly","volume":"62","author":"Amery","year":"1986","journal-title":"Postgraduate Medical Journal"},{"issue":"8442","key":"10.1002\/14651858.CD001841.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(85)91783-0","article-title":"Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial","volume":"1","author":"Amery","year":"1985","journal-title":"Lancet"},{"issue":"8507","key":"10.1002\/14651858.CD001841.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0140-6736(86)92424-4","article-title":"Efficacy of antihypertensive drug treatment according to age, sex, blood pressure and previous cardiovascular disease in patients over age of 60","volume":"2","author":"Amery","year":"1986","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD001841.pub3-BIB0020|cit20","first-page":"S642","article-title":"Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. European Working Party on High blood pressure in the Elderly (EWPHE) results: sub-group analysis on entry stratification","volume":"4","author":"Amery","year":"1986","journal-title":"Journal of Hypertension"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001841.pub3-BIB0021|cit21","first-page":"S501","article-title":"Influence of hypotensive drug treatment in elderly hypertensives: study terminating events in the trial of the European Working Party on High Blood Pressure in the Elderly","volume":"3","author":"Amery","year":"1985","journal-title":"Journal of Hypertension"},{"issue":"Suppl","key":"10.1002\/14651858.CD001841.pub3-BIB0022|cit22","first-page":"71s","article-title":"European Working Party on High Blood Pressure in the Elderly (EWPHE): organization of a double-blind multicenter trial on antihypertensive therapy in elderly patients","volume":"45","author":"Amery","year":"1973","journal-title":"Clinical Science and Molecular Medicine"},{"issue":"Suppl 3A","key":"10.1002\/14651858.CD001841.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/0002-9343(91)90427-Y","article-title":"The European Working Party on High Blood Pressure in the Elderly","volume":"90","author":"Amery","year":"1991","journal-title":"The American Journal of Medicine"},{"issue":"Suppl 3A","key":"10.1002\/14651858.CD001841.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1016\/0002-9343(91)90436-2","article-title":"Renal function in the elderly: results from the European Working Party on High Blood Pressure in the Elderly trial","volume":"90","author":"Leeuw","year":"1991","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0025|cit25","first-page":"300","article-title":"An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization","volume":"275","author":"European Working Party on High Blood Pressure in the Elderly (EWPHE)","year":"1985","journal-title":"Archives internationales de pharmacodynamie et de th\u00e9rapie"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0026|cit26","first-page":"165","article-title":"Antihypertensive therapy in the elderly. Ninth interim report","volume":"27","author":"European Working Party on High Blood Pressure in the Elderly (EWPHE)","year":"1984","journal-title":"Netherlands Journal of Medicine"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001841.pub3-BIB0027|cit27","first-page":"S509","article-title":"Discussion after the presentation of the results of the European Working Party on High Blood Pressure in the Elderly trial (EWPHE)","volume":"3","author":"European Working Party on high blood pressure in the elderly trial","year":"1985","journal-title":"Journal of Hypertension"},{"issue":"Suppl 3A","key":"10.1002\/14651858.CD001841.pub3-BIB0029|cit28","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1016\/0002-9343(91)90440-9","article-title":"Serum cholesterol levels and survival in elderly hypertensive patients: analysis of data from the European Working Party on High Blood Pressure in the Elderly","volume":"90","author":"Fagard","year":"1991","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0028|cit29","first-page":"463","article-title":"Experience with diuretics in the study conducted by the European Working Party on High Blood Pressure in the Elderly (EWPHE)","volume":"9","author":"Fagard","year":"1992","journal-title":"Progress in Pharmacology and Clinical Pharmacology"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00004872-199103000-00005","article-title":"Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly","volume":"9","author":"Fletcher","year":"1991","journal-title":"Journal of Hypertension"},{"issue":"Suppl 3A","key":"10.1002\/14651858.CD001841.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1016\/0002-9343(91)90435-Z","article-title":"Adverse treatment effects in the trial of the European Working Party on High Blood Pressure in the Elderly","volume":"90","author":"Fletcher","year":"1991","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/BF00114228","article-title":"Further learnings from the European Working Party on High Blood Pressure in the Elderly (EWPHE) study: focus on systolic hypertension","volume":"4","author":"O'Malley","year":"1990","journal-title":"Cardiovascular Drugs and Therapy."},{"issue":"suppl 1","key":"10.1002\/14651858.CD001841.pub3-BIB0033|cit33","first-page":"S105","article-title":"Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly","volume":"6","author":"O'Malley","year":"1988","journal-title":"Journal of Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD001841.pub3-BIB0034|cit34","first-page":"35","article-title":"Overview of the findings of the European Party on High Blood Pressure in the Elderly","volume":"9","author":"Prisant","year":"1990","journal-title":"Geriatric Medicine Today"},{"issue":"Suppl 3A","key":"10.1002\/14651858.CD001841.pub3-BIB0035|cit35","first-page":"50S","article-title":"The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial","volume":"90","author":"Staeesen","year":"1991","journal-title":"The American Journal of Medicine"},{"issue":"Suppl 3A","key":"10.1002\/14651858.CD001841.pub3-BIB0037|cit36","doi-asserted-by":"crossref","first-page":"60S","DOI":"10.1016\/0002-9343(91)90439-5","article-title":"Mortality and treatment of blood pressure in patients of the European Working Party on High Blood Pressure in the Elderly","volume":"90","author":"Staessen","year":"1991","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0036|cit37","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1136\/bmj.298.6687.1552","article-title":"Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly","volume":"298","author":"Staessen","year":"1989","journal-title":"BMJ"},{"issue":"Suppl 3A","key":"10.1002\/14651858.CD001841.pub3-BIB0038|cit38","first-page":"24S","article-title":"Age-related hypotensive effect of placebo and active treatment in patients older than 60 years","volume":"90","author":"Thijs","year":"1991","journal-title":"The American Journal of Medicine"},{"issue":"Suppl 3A","key":"10.1002\/14651858.CD001841.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/0002-9343(91)90434-Y","article-title":"Body mass index and prognosis in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly","volume":"90","author":"Tuomilehto","year":"1991","journal-title":"The American Journal of Medicine"},{"issue":"Suppl 3A","key":"10.1002\/14651858.CD001841.pub3-BIB0041|cit40","doi-asserted-by":"crossref","first-page":"55s","DOI":"10.1016\/0002-9343(91)90438-4","article-title":"Left ventricular hypertrophy in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly trial","volume":"90","author":"Hoof","year":"1991","journal-title":"The American Journal of Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001841.pub3-BIB0040|cit41","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1097\/00005344-199117002-00020","article-title":"The effect of antihypertensive treatment on electrocardiogram voltages in the European Working Party on High Blood Pressure in the Elderly trial","volume":"17","author":"Hoof","year":"1991","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0042|cit42","first-page":"127","article-title":"The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events","volume":"12","author":"The HOPE Study Investigators","year":"1996","journal-title":"Canadian Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD001841.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Outcomes Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.1974.03230420021019","article-title":"Effect of antihypertensive treatment on stroke recurrence","volume":"229","author":"Hypertension-Stroke Cooperative Study Group","year":"1974","journal-title":"JAMA"},{"issue":"18","key":"10.1002\/14651858.CD001841.pub3-BIB0045|cit45","first-page":"1887","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"New Egyptian Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD001841.pub3-BIB0046|cit46","first-page":"631","article-title":"The Hypertension in the Very Elderly Trial (HYVET)","volume":"8","author":"Bulpitt","year":"1994","journal-title":"Journal of Human Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD001841.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002512-199405030-00003","article-title":"The Hypertension in the Very Elderly Trial (HYVET): rationale, methodology and comparison with previous trials","volume":"5","author":"Bulpitt","year":"1994","journal-title":"Drugs & Aging"},{"issue":"8","key":"10.1002\/14651858.CD001841.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD001841.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/sj.jhh.1000901","article-title":"Orthostatic fall in blood pressure in the very elderly: results from the Hypertension in the Very Elderly trial (HYVET) - pilot","volume":"13","author":"Beckett","year":"1999","journal-title":"Journal of Human Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/00004872-200312000-00030","article-title":"Results of the pilot study for the Hypertension in the Very Elderly Trial","volume":"21","author":"Bulpitt","year":"2003","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1536\/ihj.22.75","article-title":"Prospective study on the treatment of mild hypertension in the aged","volume":"22","author":"Kuramoto","year":"1981","journal-title":"Japanese Heart Journal"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medical Research Council trial of treatment of hypertension in older adults: principal results","volume":"304","author":"MRC Working Party","year":"1992","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD001841.pub3-BIB0059|cit53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/j.1552-4604.1987.tb03012.x","article-title":"Comparison of the antihypertensive efficacy and adverse reactions to two doses of bendrofluazide and hydrochlorothiazide and the effect of potassium supplementation on the hypotensive action of bendrofluazide: sub studies of the Medical Research Council's trials of treatment of hypertension: Medical Research Council Working Party","volume":"27","author":"Medical Research Council Working Party","year":"1987","journal-title":"Journal of Clinical Pharmacology"},{"issue":"6074","key":"10.1002\/14651858.CD001841.pub3-BIB0060|cit54","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/bmj.1.6074.1437","article-title":"Randomised controlled trial of treatment of mild hypertension: design and pilot trial. Report of the Medical Research Council Working party on Mild to Moderate Hypertension","volume":"1","author":"Medical Research Council Working Party","year":"1977","journal-title":"British Medical Journal"},{"issue":"8246","key":"10.1002\/14651858.CD001841.pub3-BIB0053|cit55","first-page":"539","article-title":"Adverse reactions to bendrofluazide and propanolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension","volume":"2","author":"Medical Research Council Working Party on Mild Hypertension","year":"1981","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001841.pub3-BIB0054|cit56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/j.1552-4604.1987.tb03012.x","article-title":"Comparison of the antihypertensive efficacy and adverse reactions of two doses of bendrofluazide and hydrochlorothiazide and the effect of potassium supplementation on the hypotensive action of bendrofluazide: sub studies of the Medical Research Council's trials of treatment of mild hypertension","volume":"27","author":"Medical Research Council Working Party on Mild Hypertension","year":"1987","journal-title":"Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD001841.pub3-BIB0055|cit57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/hrt.59.3.364","article-title":"Coronary heart disease in Medical Research Council trial of mild hypertension","volume":"59","author":"Medical Research Council Working Party on Mild Hypertension","year":"1988","journal-title":"British Heart Journal"},{"issue":"6553","key":"10.1002\/14651858.CD001841.pub3-BIB0056|cit58","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bmj.293.6553.988","article-title":"Course of blood pressure in mild hypertension after withdrawal of long term antihypertensive treatment","volume":"293","author":"Medical Research Council Working Party on Mild Hypertension","year":"1986","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"issue":"6488","key":"10.1002\/14651858.CD001841.pub3-BIB0057|cit59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.291.6488.97","article-title":"MRC trial of treatment of mild hypertension: principal results","volume":"291","author":"Medical Research Council Working Party on Mild Hypertension","year":"1985","journal-title":"British Medical Journal"},{"issue":"6636","key":"10.1002\/14651858.CD001841.pub3-BIB0058|cit60","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1136\/bmj.296.6636.1565","article-title":"Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment","volume":"296","author":"Medical Research Council Working Party on Mild Hypertension","year":"1988","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0061|cit61","first-page":"563s","article-title":"Medical Research Council's Treatment Trial for mild hypertension: an interim report","volume":"51","author":"Miall","year":"1976","journal-title":"Clinical Science and Molecular Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001841.pub3-BIB0062|cit62","first-page":"616","article-title":"Results of the MRC (UK) trial of drug therapy for mild hypertension","volume":"10","author":"Peart","year":"1987","journal-title":"Clinical and Investigative Medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0067|cit63","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9343(80)90438-6","article-title":"Treatment of mild hypertension: a five year controlled drug trial. The Oslo study","volume":"69","author":"Helgeland","year":"1980","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0063|cit64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0954-6820.1979.tb00805.x","article-title":"Mild hypertension - early drug treatment or follow-up only? the Oslo study","volume":"626","author":"Helgeland","year":"1979","journal-title":"Acta Medica Scandinavica. Supplementum"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0064|cit65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0002-9343(78)90177-8","article-title":"Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension","volume":"64","author":"Helgeland","year":"1978","journal-title":"American Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001841.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000184565","article-title":"Oslo study: treatment of mild hypertension. A five-year controlled drug study","volume":"47","author":"Helgeland","year":"1987","journal-title":"Nephron"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0065|cit67","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0002-9343(84)90990-2","article-title":"Serum glucose levels during long-term observation of treated and untreated men with mild hypertension","volume":"76","author":"Helgeland","year":"1984","journal-title":"American Journal of Medicine"},{"issue":"7-8","key":"10.1002\/14651858.CD001841.pub3-BIB0068|cit68","first-page":"80","article-title":"Coronary risk factors and their possible causal role in the development of coronary heart disease: the Oslo study","volume":"32","author":"Holme","year":"1982","journal-title":"Journal of the Oslo City Hospitals"},{"issue":"4","key":"10.1002\/14651858.CD001841.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/oxfordjournals.aje.a114855","article-title":"Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo Study","volume":"127","author":"Holme","year":"1988","journal-title":"American Journal of Epidemiology"},{"issue":"Suppl II","key":"10.1002\/14651858.CD001841.pub3-BIB0070|cit70","first-page":"217","article-title":"Blood lipids and antihypertensive drugs. The Oslo study","volume":"14","author":"Leren","year":"1983","journal-title":"Journal de pharmacologie (Paris)"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-8703(83)90175-8","article-title":"The Oslo study: CHD risk factors, socioeconomic influences, and interventions","volume":"106","author":"Leren","year":"1983","journal-title":"American Heart Journal"},{"issue":"Suppl 2A","key":"10.1002\/14651858.CD001841.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(86)90153-1","article-title":"Coronary heart disease and treatment of hypertension. Some Oslo Study data","volume":"80","author":"Leren","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001841.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003495-198600311-00008","article-title":"Oslo hypertension study","volume":"31","author":"Leren","year":"1986","journal-title":"Drugs"},{"issue":"9","key":"10.1002\/14651858.CD001841.pub3-BIB0074|cit74","first-page":"710","article-title":"Post-stroke antihypertensive treatment study. A preliminary result","volume":"108","author":"PATS collaborating group","year":"1995","journal-title":"Chinese Medical Journal"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1532-5415.1991.tb02869.x","article-title":"Prevalence of postural hypotension at baseline in the systolic hypertension in the elderly program (SHEP) cohort","volume":"39","author":"Applegate","year":"1991","journal-title":"Journal of American Geriatric Society"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1532-5415.1994.tb06979.x","article-title":"Age, race, and gender variation in the utilization of coronary artery bypass surgery and angioplasty in SHEP","volume":"42","author":"Bearden D. Allman R. McDonald","year":"1994","journal-title":"Journal of the American Geriatric Society"},{"issue":"3 (Suppl II)","key":"10.1002\/14651858.CD001841.pub3-BIB0077|cit77","first-page":"II","article-title":"Part 6: Baseline physical examination findings","volume":"17","author":"Black HR. Unger D. Burlando","year":"1991","journal-title":"Hypertension"},{"issue":"3 (Suppl II)","key":"10.1002\/14651858.CD001841.pub3-BIB0078|cit78","first-page":"II","article-title":"Part 1: rationale and design","volume":"17","author":"Borhani NO. Applegate WB. Cutler","year":"1991","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-0258(19970330)16:6<681::AID-SIM487>3.0.CO;2-H","article-title":"Blinded subjective rankings as a method of assessing treatment effect: a large sample example from the systolic hypertension in the elderly program (SHEP)","volume":"16","author":"Brittain E. Palensky J. Blood J and Wittes J","year":"1997","journal-title":"Statistics in Medicine"},{"issue":"3 (Suppl II)","key":"10.1002\/14651858.CD001841.pub3-BIB0080|cit80","first-page":"II","article-title":"Part 4: baseline medical history findings","volume":"17","author":"Curb JD. Lee M. Jensen","year":"1991","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension","volume":"276","author":"Curb JD. Pressel SL. Cutler","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0197-2456(93)90051-E","article-title":"Statistical considerations in monitoring the systolic hypertension in the elderly program (SHEP)","volume":"14","author":"Davis BR. Wittes J. Pressel","year":"1993","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00004872-200018080-00021","article-title":"serum uric acid, diuretic treatment and risk of cardiovascular events in the systolic hypertension in the elderly program","volume":"18","author":"Franse LV. Pahor M. Di Bari","year":"2000","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/01.CIR.94.10.2381","article-title":"Serum lipids and incidence of coronary heart disease. Findings from the systolic hypertension in the elderly program","volume":"94","author":"Frost PH. Davis BR. Burlando","year":"1996","journal-title":"Circulation"},{"issue":"3 (Suppl II)","key":"10.1002\/14651858.CD001841.pub3-BIB0085|cit85","first-page":"II","article-title":"Part 7: Baseline laboratory characteristics","volume":"17","author":"Hall WD. Davis BR. Frost","year":"1991","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0086|cit86","first-page":"25","article-title":"Isolated systolic hypertension, morbidity and mortality: The SHEP experience","volume":"September\/Octob","author":"Hawkins","year":"1993","journal-title":"American Journal of Geriatric Cardiology"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0002-8703(94)90516-9","article-title":"Correlates of ventricular ectopic activity in isolated systolic hypertension","volume":"127","author":"Kostis JB. Allen R. Berkson","year":"1994","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD001841.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.1997.03550030052033","article-title":"Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension","volume":"278","author":"Kostis JB. Davis BR. Cutler","year":"1997","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0002-9149(94)90904-0","article-title":"The effect of chlorthalidone on ventricular ectopic activity in patients with isolated systolic hypertension","volume":"74","author":"Kostis JB. Lacy CR. Hall","year":"1994","journal-title":"American Journal of Cardiology"},{"issue":"3 (Suppl II)","key":"10.1002\/14651858.CD001841.pub3-BIB0090|cit90","first-page":"II","article-title":"Part 8: Electrocardiographic characteristics","volume":"17","author":"Kostis JB. Prineas R. Curb","year":"1991","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ajh\/5.5.325","article-title":"Some lessons from systolic hypertension in the elderly program (SHEP)","volume":"5","author":"Menard J. Day M. Chatellier","year":"1992","journal-title":"American Journal of Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1532-5415.1997.tb03198.x","article-title":"Mortality over four years in SHEP participants with a low ankle-arm index","volume":"45","author":"Newman AB. Tyrrell","year":"1997","journal-title":"Journal of American Geriatric Society"},{"issue":"4","key":"10.1002\/14651858.CD001841.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.284.4.465","article-title":"Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke","volume":"284","author":"Perry HM. Davis BR. Price","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD001841.pub3-BIB0094|cit94","first-page":"II","article-title":"Part 2: screening and recruitment","volume":"17 (Suppl II)","author":"Petrovich H. Byington R. Bailey","year":"1991","journal-title":"Hypertension"},{"issue":"5 & 6","key":"10.1002\/14651858.CD001841.pub3-BIB0095|cit95","first-page":"973","article-title":"The systolic hypertension in the elderly program (SHEP): an intervention trial on isolated systolic hypertension","volume":"A11","author":"Probstfield JL. Applegate WB. Borhani","year":"1989","journal-title":"Clinc. and Exper. Hyper.-Theory and Practice"},{"issue":"12","key":"10.1002\/14651858.CD001841.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0895-4356(88)90024-8","article-title":"Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension","volume":"41","author":"SHEP cooperative Research Group","year":"1988","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD001841.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7326\/ACPJC-1991-115-3-065","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the SHEP","volume":"115","author":"SHEP cooperative research group","year":"1991","journal-title":"ACP Journal Club"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program","volume":"265","author":"SHEP cooperative research group","year":"1991","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.158.7.741","article-title":"Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension","volume":"158","author":"Savage PJ. Pressel SL. Curb","year":"1998","journal-title":"Archives of Internal Medicine"},{"issue":"3 (Suppl II)","key":"10.1002\/14651858.CD001841.pub3-BIB0100|cit100","first-page":"II","article-title":"Part 3: Sociodemographic characteristics","volume":"17","author":"Vogt TM. Schron E. Pressel","year":"1991","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.1996.00440050111012","article-title":"Change in depression as a precursor of cardiovascular events","volume":"156","author":"Wassertheil S. Applegate WB. Berge","year":"1996","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/archinte.160.4.494","article-title":"Relation of low body mass to death and stroke in the systolic hypertension in the elderly program","volume":"160","author":"Wasserthell-Smoller S. FannC. Allman","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"3 (Suppl II)","key":"10.1002\/14651858.CD001841.pub3-BIB0103|cit103","first-page":"II","article-title":"Part 9: Behavorial characteristics","volume":"17","author":"Weiler PG. Camel GH. Chiappini","year":"1991","journal-title":"Hypertension"},{"issue":"3 (Suppl II)","key":"10.1002\/14651858.CD001841.pub3-BIB0104|cit104","first-page":"II","article-title":"Part 10: Analysis","volume":"17","author":"Wittes J. Davis B. Berge","year":"1991","journal-title":"Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD001841.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/geronj\/42.5.552","article-title":"Compliance to treatment for hypertension in elderly patients: The SHEP pilot study","volume":"42","author":"Black DM. Brand RJ. Greenlick","year":"1987","journal-title":"Journal of Gerontology"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/oxfordjournals.eurheartj.a062487","article-title":"The systolic hypertension in the elderly program: Methodological issues","volume":"9","author":"Furberg CD. Black DM. for the SHEP research group","year":"1988","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD001841.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1532-5415.1986.tb05476.x","article-title":"Systolic hypertension in the elderly program (SHEP)","volume":"34","author":"Hulley SB. Feigal D. Ireland","year":"1986","journal-title":"Journal of the American Geriatric Society"},{"issue":"15","key":"10.1002\/14651858.CD001841.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0002-9149(85)90404-7","article-title":"Systolic Hypertension in the Elderly (SHEP): antihypertensive efficacy of chlorthalidone","volume":"56","author":"Hulley SB. Furberg CD. Gurland B. McDonald","year":"1985","journal-title":"The American Journal of cardiology"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.20.1.4","article-title":"Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) Pilot study","volume":"20","author":"Perry","year":"1989","journal-title":"Stroke"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD001841.pub3-BIB0110|cit110","first-page":"S21","article-title":"Systolic hypertension in the elderly program, pilot study (SHEP-PS): morbidity and mortality experience","volume":"4","author":"Perry Jr HM. McDonald RH. Hulley","year":"1986","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0197-2456(86)90028-0","article-title":"Recruitment of elderly volunteers for a multicenter clinical trial: The SHEP pilot study","volume":"7","author":"Vogt TM. Ireland CC. Black","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-3797(18)31211-X","article-title":"Relation of life events to blood pressure control in the SHEP trial","volume":"4","author":"Vogt TM. Ireland CC. Greenlick","year":"1988","journal-title":"American Journal of Preventive Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001841.pub3-BIB0113|cit113","first-page":"287","article-title":"Syst-Eur. A multicenter trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol and organization","volume":"3","author":"Amery A. Birkenhager W. Bulpitt","year":"1991","journal-title":"Aging"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0114|cit114","first-page":"232","article-title":"Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the systolic hypertension in Europe (Syst-Eur) trial","volume":"13","author":"Birkenhager WH. Staessen J. Gasowski","year":"2000","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1007891121240","article-title":"Benefit of antihypertensive treatment in diabetic patients enrolled in the systolic hypertension in Europe (Sys-Eur) trial","volume":"14","author":"Gasowski J. Birkenhager WH. Staessen","year":"2000","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"8","key":"10.1002\/14651858.CD001841.pub3-BIB0116|cit116","first-page":"1243","article-title":"SYST-EUR: a multicenter trial of treatment of systolic hypertension in aged subjects. An initial report (French)","volume":"85","author":"Girerd","year":"1992","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"issue":"4","key":"10.1002\/14651858.CD001841.pub3-BIB0117|cit117","first-page":"411","article-title":"Nitrendipine in older patients with isolated systolic hypertension: second progress report on the Syst-Eur trial","volume":"7","author":"Slovick","year":"1993","journal-title":"J Hum Hypertens"},{"issue":"2","key":"10.1002\/14651858.CD001841.pub3-BIB0118|cit118","first-page":"201","article-title":"Syst-Eur multicenter trial on the treatment of isolated hypertension in the elderly: first interim report","volume":"7","author":"Slovick","year":"1993","journal-title":"J Hum Hypertens"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001841.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/00005344-199106181-00008","article-title":"Treatment of isolated systolic hypertension","volume":"18","author":"Staessen J. Dekempeneer L. Fagard","year":"1991","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00005344-199201000-00017","article-title":"Syst-Eur- a multicenter trial on treatment of isolated systolic hypertension in the elderly: first interim report","volume":"19","author":"Staessen JA. Amery A. Birkenhager","year":"1992","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"Staessen JA. Fagard R. Thijs L. Celis H. Arabidze","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/archinte.158.15.1681","article-title":"Subgroup and per protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly","volume":"158","author":"Staessen JA. Fagard R. Thijs","year":"1998","journal-title":"Archives of Internal medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000107813","article-title":"Atenolol for secondary prevention after stroke","volume":"5","author":"Eriksson","year":"1995","journal-title":"Cerebrovasc Dis"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"Brit Med J"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"Brit Med J"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/BF00400195","article-title":"UK prospective diabetes study VIII: study design, progress and performance","volume":"34","author":"United Kingdom Prospective Diabetes Study Group","year":"1991","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0127|cit127","first-page":"110","article-title":"Morbidity and mortality in mild essential hypertension","volume":"30\/31(Suppl II)","author":"Smith","year":"1972","journal-title":"Circ Res"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0128|cit128","first-page":"461","article-title":"Intervention trial in mild hypertension,U.S. Public Health Service Hospitals Cooperative Study Group","volume-title":"Intervention trial in mild hypertension, U.S. Public Health Service Hospitals Cooperative Study Group","author":"Smith","year":"1975"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001841.pub3-BIB0129|cit129","first-page":"98","article-title":"Treatment of mild hypertension. Results of a ten-year intervention trial","volume":"40","author":"US. public health service hospital cooperative study group (USPHSHCSG)","year":"1977","journal-title":"Circ Res"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0130|cit130","first-page":"345","article-title":"Antihypertensive Therapy; Principles and Practice, an International Symposium","volume-title":"Antihypertensive Therapy; Principles and Practice, an International Symposium","author":"Freis","year":"1966"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archinte.1962.03620200090016","article-title":"A double-blind control study of antihypertensive agents. III. Chlorothiazide alone and in combination with other agents: preliminary results","volume":"110","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1962","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jama.1967.03130240070013","article-title":"Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg","volume":"202","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1967","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.1970.03170330025003","article-title":"Effects of treatment on morbidity in hypertension II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg","volume":"213","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1970","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0134|cit134","first-page":"267","article-title":"Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial","volume":"304","author":"Perry Jr","year":"1978","journal-title":"Ann N Y Acad Sci"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0135|cit135","first-page":"1180","article-title":"Treatment of mild hypertension. Preliminary results of a two year feasibility trial","volume":"40 suppl","author":"Perry Jr","year":"1977","journal-title":"Circ Res"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0021-9681(66)90128-7","article-title":"Effects of treatment in hypertension. Results of a controlled study","volume":"19","author":"Wolff","year":"1966","journal-title":"J Chron Dis"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1008816","article-title":"Irbesartan in patients ACTIVE 1 with atrial fibrillation","volume":"364","author":"The Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE I)Investigators","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)","volume":"283","author":"ALLHAT Group","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0895-7061(96)00037-4","article-title":"Rationale and design for the Antihypertensive and Lipid Lowering Treatment to prevent Heart Attack Trial (ALLHAT)","volume":"9","author":"Davis BR. Cutler JA. Gordon DJ. et al for the ALLHAT Research Group","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on teh development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(81)92624-6","article-title":"Beta-blockers of diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects","volume":"I","author":"Berglund G. Andersson","year":"1981","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD001841.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1536\/ihj.35.589","article-title":"Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL)","volume":"35","author":"Casigila E. Spolaore P. Mazza A. Ginocchio","year":"1994","journal-title":"Jpn Heart J"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/bmj.293.6555.1145","article-title":"Randomised trial of treatment of hypertension in elderly patients in primary care","volume":"293","author":"Coope","year":"1986","journal-title":"Brit Med J"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/bmj.37970.629537.0D","article-title":"Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)","volume":"328","author":"Marre","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa065061","article-title":"Effect of ramipril on the incidence of diabetes. The DREAM trial investigators","volume":"355","author":"DREAM trial investigators","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of- cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"issue":"65","key":"10.1002\/14651858.CD001841.pub3-BIB0149|cit149","first-page":"1","article-title":"Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial","volume":"12","author":"Fuchs","year":"2011","journal-title":"Trials"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0150|cit150","first-page":"536","article-title":"Efficacy and safety of nebivolol monotherapy in Hispanics with Stage I-II Hypertension (Abstract)","volume":"12","author":"Punzi","year":"2010","journal-title":"Journal of clinical hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0151|cit151","first-page":"2001","article-title":"Predictors of antihypertensive drug responses: initial data from a placebo-controlled , randomized, cross over study with four antihypertensive drugs","volume":"27","author":"Hitunen","year":"2009","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1291\/hypres.18.235","article-title":"A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension- the GLANT study","volume":"18","author":"Study Group on Long-term Antihypertensive Therapy","year":"1995","journal-title":"Hypertens Res"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00004872-198710000-00009","article-title":"Beta-blockers versus diuretics in hypertensive men: Main results from the HAPPHY trial","volume":"5","author":"Wilhelmsen L. Berglund B. Elmfeldt D. Fitzsimons","year":"1987","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001841.pub3-BIB0154|cit154","first-page":"198","article-title":"Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. 5-year findings of the hypertension detection and follow-up program","volume":"6","author":"HDFP","year":"1984","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.107.690396","article-title":"The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio","volume":"116","author":"Hood","year":"2007","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1002\/14651858.CD001841.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/08037059509077613","article-title":"The Hypertension Optimal Treatment (HOT) Study: 12-month Data on Blood Pressure and Tolerability. With Special Reference to Age and Gender","volume":"4","author":"Hansson","year":"1995","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/0003-4819-138-7-200304010-00010","article-title":"Cardiovascular outcomes in the Irbesartan diabetic nephropathy trial of patients with type 2 diabetes and overt nephropathy","volume":"138","author":"Berl","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.106.685073","article-title":"Effects of angiotensin converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery","volume":"117","author":"Rouleau","year":"2008","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1007\/s00125-011-2325-z","article-title":"Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study","volume":"54","author":"Imai","year":"2011","journal-title":"Diabetologia"},{"issue":"(Suppl3)","key":"10.1002\/14651858.CD001841.pub3-BIB0162|cit162","first-page":"S157","article-title":"INSIGHT: International Nifedipine GITS study: Intervention as a goal in hypertension treatment","volume":"10","author":"Brown MJ. Castaigne A. De Leeuw PW. Mancia","year":"1996","journal-title":"J Hum Hypertens"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004872-198508000-00011","article-title":"Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker, oxprenolol: The international prospective primary prevention study in hypertension (IPPPSH)","volume":"3","author":"The IPPPSH Collaborative Group","year":"1985","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1016\/S0002-8703(03)00443-5","article-title":"Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease","volume":"146","author":"Kondo","year":"2003","journal-title":"Am Heart J"},{"issue":"6","key":"10.1002\/14651858.CD001841.pub3-BIB0165|cit165","first-page":"S35","article-title":"Treatment of the elderly hypertensives in Japan: National Intervention Cooperative Study in Elderly Hypertensives. The National Intervention Cooperative study Group","volume":"12","author":"Kuramoto","year":"1994","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to Type 2 Diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0735-1097(00)00736-1","article-title":"Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease","volume":"36","author":"MacMahon","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.1988.03720130040027","article-title":"Primary prevention with metoprolol in patients with hypertension: mortality results from the MAPHY study","volume":"259","author":"Wikstrand J. Warnold I. Olsson","year":"1988","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0170|cit170","first-page":"579","article-title":"Metoprolol versus thiazide diuretics in hypertension","volume":"17","author":"Wikstrand","year":"1991","journal-title":"Morbidity results from the MAPHYstudy Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0171|cit171","first-page":"914","article-title":"Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo","volume":"328","author":"Materson BJ. Reda DJ. Cushman WC. Massie","year":"1997","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.1996.03540100029024","article-title":"Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS) A randomised controlled trial","volume":"276","author":"Borhani NO. Mercuri M. Borhani PA. Buckalew VM. Canossa-Terris","year":"1996","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD001841.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5694\/j.1326-5377.1980.tb131808.x","article-title":"Failure of therapy to improve prognosis in elderly males with hypertension","volume":"2","author":"Morgan TO. Adams WR. Hodgson","year":"1980","journal-title":"Med J Aust"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1001121","article-title":"Effect of valsartan on the incidence of diabetes and cardiovascular events","volume":"362","author":"McMurray","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/heart.89.8.887","article-title":"Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study","volume":"89","author":"Dens","year":"2003","journal-title":"Heart"},{"issue":"9227","key":"10.1002\/14651858.CD001841.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)02526-5","article-title":"Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Dilitazem (NORDIL) study","volume":"356","author":"Hansson L. Hedner T. Lund-Johnson P. Kjeldsen","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin converting- enzyme inhibition in stable coronary artery disease","volume":"351","author":"Braunwald","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1002\/14651858.CD001841.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clinthera.2007.01.007","article-title":"Comparison of valsartan\/hydrochlorothiazide combination therapy at doses up to 320\/25mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults","volume":"29","author":"Pool","year":"2007","journal-title":"Clin Ther"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack.","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0002-9149(01)01461-8","article-title":"The QUinapril Ischemic Event Trial (QUIET): Evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function","volume":"87","author":"Pitt","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","author":"GISEN Group","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2006121372","article-title":"Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency","volume":"18","author":"Hou","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/ijs.12418","article-title":"Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis","volume":"10","author":"Jusufovic","year":"2015","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/01.CIR.102.15.1748","article-title":"Long-term effects of cholesterol lowering and angiotensin converting enzyme inhibition on coronary atherosclerosis.","volume":"102","author":"Teo","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.107.750745","article-title":"Long-term antihypertensive efficacy and safety of the oral direct renin Inhibitor aliskiren. A 12-month randomized, double-blind comparator trial with hydrochlorothiazide","volume":"119","author":"Schmieder","year":"2009","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD001841.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/00004872-199512002-00006","article-title":"Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and European Lacidipine Study on Atherosclerosis (ELSA)","volume":"13","author":"Zanchetti","year":"1995","journal-title":"J of Hypertension- supplement"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.283.6300.1151","article-title":"Blood pressure reduction in the elderly: a randomised controlled trial of methyldopa","volume":"283","author":"Sprackling","year":"1981","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/00004872-199610000-00013","article-title":"Shanghai Trial of Nifedipine in the Elderly (STONE) Study","volume":"14","author":"Gong L. Zwang W. Zhu","year":"1996","journal-title":"J Hypertens"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(91)92589-T","article-title":"Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOPHypertension)","volume":"338","author":"Dahlof","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/08037059309077541","article-title":"STOP - Hypertension 2: A prospective intervention trial of \"newer\" vs \"older\" treatment alternatives in old patients with hypertension","volume":"2","author":"Dahlof B. Hansson L. Lindholm","year":"1993","journal-title":"Blood Pressure"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.1991.03470090059032","article-title":"Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men","volume":"266","author":"Strandberg","year":"1991","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD001841.pub3-BIB0196|cit196","first-page":"135","article-title":"[Systolic hypertension in the elderly: Chinese trial (Syst-China)--second interim report]","volume":"21","author":"Anonymous","year":"1993","journal-title":"[Chinese] Chung-Hua Hsin Hsueh Kuan Ping Tsa Chih [Chinese Journal of Cardiology]"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.1993.03510060059034","article-title":"Treatment of mild hypertension study. Final results","volume":"270","author":"Neaton JD. Brimm RH. Prineas","year":"1993","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1001\/jama.1982.03330160052024","article-title":"Comparison of propanolol and hydrochlorothiazide for the initial treatment of hypertension. II Results of long term therapy","volume":"248","author":"Veterans Administrative Cooperative Study Group on Antihypertensive Agents","year":"1982","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00004872-199715110-00019","article-title":"Clinical results of the verapamil in hypertension and atherosclerosis study.","volume":"15","author":"Agabiti","year":"1997","journal-title":"J Hypertens"},{"issue":"11","key":"10.1002\/14651858.CD001841.pub3-BIB0201|cit201","first-page":"879","article-title":"Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension","volume":"9","author":"White","year":"1995","journal-title":"J Hum Hypertension"},{"issue":"12","key":"10.1002\/14651858.CD001841.pub3-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archinte.165.12.1410","article-title":"Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.","volume":"165","author":"Turnbull","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1472-8206.2005.00356.x","article-title":"Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments.","volume":"19","author":"Boissel","year":"2005","journal-title":"Fund Clin Pharmacol"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0204|cit204","first-page":"1955","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: results of prospectively designed overviews of randomised trials","volume":"355","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD001841.pub3-BIB0205|cit205","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003654.pub4","article-title":"Calcium channel blocker versus other classes of drugs for hypertension","author":"Chen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease- Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD001841.pub3-BIB0207|cit207","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006742.pub2","article-title":"Pharmacotherapy for mild hypertension","author":"Diao","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD001841.pub3-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/erc.10.27","article-title":"Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics","volume":"8","author":"Duarte","year":"2010","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"10.1002\/14651858.CD001841.pub3-BIB0209|cit209","first-page":"153","volume-title":"Current Cardiovascular Drugs","author":"Frishman","year":"2005"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s40266-014-0219-8","article-title":"Pharmacotherapy for Hypertension in Older Adults: A Systematic Review","volume":"31","author":"Goeres","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0211|cit211","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0212|cit212","first-page":"1","article-title":"New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit","volume":"10","author":"Gueyffier F. Froment","year":"1996","journal-title":"J Human Hyperten"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(98)08127-6","article-title":"Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials","volume":"353","author":"Gueyffier","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0214|cit214","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0215|cit215","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011"},{"issue":"4","key":"10.1002\/14651858.CD001841.pub3-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3317\/jraas.2004.034","article-title":"\"How do thiazide and thiazide-like diuretics lower blood pressure?\"","volume":"5","author":"Hughes","year":"2004","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7326\/0003-4819-121-5-199409010-00008","article-title":"Drug treatment of hypertension in the elderly: A meta-analysis","volume":"121","author":"Insua JT. Sacks HS. Lau TS. Lau","year":"1994","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1002\/14651858.CD001841.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0149-2918(04)90024-0","article-title":"A Systematic Review and Meta-Analysis of the Efficacy and Safety of a Fixed,Low-Dose Perindopril-Indapamide Combination as First-Line Treatment of Hypertension","volume":"26","author":"Kang","year":"2004","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD001841.pub3-BIB0219|cit219","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5543\/tkda.2016.78006","article-title":"Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials","volume":"45","author":"K\u0131z\u0131l\u0131rmak","year":"2017","journal-title":"Turk Kardiyol Dern Ars"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD001841.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/10641969309037085","article-title":"The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives","volume":"15","author":"MacMahon","year":"1993","journal-title":"Clin Exper Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1001\/jama.1994.03520240060042","article-title":"Hypertension in the elderly: Implications and generalizability of randomized trials","volume":"272","author":"Mulrow","year":"1994","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD001841.pub3-BIB0223|cit223","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000028","article-title":"Pharmacotherapy for hypertension in the elderly","author":"Mulrow","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001841.pub3-BIB0224|cit224","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000028.pub2","article-title":"Pharmacotherapy of hypertension in the elderly","author":"Musini","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD001841.pub3-BIB0225|cit225","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008276.pub2","article-title":"Pharmacotherapy for hypertension in adults aged 18 to 59 years","author":"Musini","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s003910070015","article-title":"Treatment of arterial hypertension with diuretics, beta- and calcium channel blockers in old patients","volume":"33","author":"Nikolaus","year":"2000","journal-title":"Z Gerontol Geriat"},{"issue":"2","key":"10.1002\/14651858.CD001841.pub3-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2217\/fca.15.90","article-title":"The effect of antihypertensive treatment on teh incidence of stroke and cognitive decline in the elderly: a meta-analysis","volume":"12","author":"Parsons","year":"2016","journal-title":"Future Cardiology"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archfami.4.11.943","article-title":"Does Antihypertensive Treatment of the Elderly Prevent Cardiovascular Events or Prolong Life? A Meta-analysis ofHypertension Treatment Trials","volume":"4","author":"Pearce","year":"1995","journal-title":"Archives of Family Medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.1997.03540330061036","article-title":"Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.","volume":"277","author":"Psaty","year":"1997","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD001841.pub3-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamainternmed.2016.6821","article-title":"Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults. Secondary analysis of a randomized clinical trial","volume":"177","author":"Puttnam","year":"2017","journal-title":"JAMA Internal Medicine"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1046\/j.1525-1497.1999.12198.x","article-title":"Efficacy of Treating Hypertension in Women","volume":"14","author":"Quan","year":"1999","journal-title":"J General Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001841.pub3-BIB0233|cit233","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008161.pub2","article-title":"First-line diuretics versus other classes of antihypertensive drugs for hypertension","author":"Reinhart","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0234|cit234","unstructured":"Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration Review Manager. Version 5.3 2014"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/M14-0773","article-title":"Effects of Blood Pressure Reduction in Mild Hypertension. A Systematic Review and Meta-analysis","volume":"162","author":"Sundstro\u00a8m","year":"2015","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001841.pub3-BIB0236|cit236","first-page":"7624","article-title":"ACEIs\/ARBs for the prevention of type 2 diabetes in patients with cardiovascular diseases: a systematic review and meta-analysis","volume":"9","author":"Tan Xue-","year":"2016","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"10.1002\/14651858.CD001841.pub3-BIB0237|cit237","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011745.pub2","article-title":"Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals","author":"Taverny","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00004872-199210000-00001","article-title":"A meta-analysis of outcome trials in elderly hypertensives","volume":"10","author":"Thijs L. Fagard R. Lijnen P. Staessen","year":"1992","journal-title":"Journal of Hypertension"},{"issue":"12","key":"10.1002\/14651858.CD001841.pub3-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/HJH.0000000000000378","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials","volume":"32","author":"Thomopoulos","year":"2014","journal-title":"Journal of Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD001841.pub3-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/HJH.0000000000000848","article-title":"Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure - Meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"March 2016","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD001841.pub3-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","author":"Turnbull F. Blood Pressure Lowering Treatment Trialists' Collaboration","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001841.pub3-BIB0242|cit242","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002003.pub2","article-title":"Beta-blockers for hypertension","author":"Wiysonge","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001841.pub3-BIB0243|cit243","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008170.pub2","article-title":"First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension","author":"Xue","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD001841.pub3-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.116.303641","article-title":"Randomized Controlled Trials of Blood Pressure Lowering in Hypertension: A Critical Reappraisal","volume":"116","author":"Zanchetti","year":"2015","journal-title":"Circulation Research"},{"issue":"2","key":"10.1002\/14651858.CD001841.pub3-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/01.HYP.0000152701.97426.5f","article-title":"Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitisation linked to Rho kinase\"","volume":"45","author":"Zhu","year":"2005","journal-title":"Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD001841.pub3-BIB0246|cit246","first-page":"25","article-title":"Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?","volume":"161","author":"Wright JM. Cheng-Han","year":"1999","journal-title":"CMAJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001841.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T03:27:04Z","timestamp":1720236424000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001841.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":246,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001841.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]}}}